Supervision of outpatient drug therapy with the medication monitor
Moulding, T.; Onstad, G.D.; Sbarbaro, J.A.
Annals of Internal Medicine 73(4): 559-564
1970
ISSN/ISBN: 0003-4819 PMID: 4319078 Document Number: 22349
Document emailed within 1 workday
Related Documents
Tellioglu, T. 2008: The use of urine drug testing to monitor patients receiving chronic opioid therapy for persistent pain conditions Medicine and Health Rhode Island 91(9): 279-280; 282Duê, L.K. 1986: How we have ensured the proper taking of medication in a multi-drug therapy program in Vietnam Acta Leprologica 4(4): 491-493
Kritzinger, N.A. 1980: Adherence to drug therapy. An outpatient survey at the Johnnesburg General Hospital South African Medical Journal 58(19): 767-770
Crosswhite, C.L. 2010: CMS modifies Medicare policies regarding supervision requirements for hospital outpatient services Journal of Medical Practice Management: Mpm 26(1): 47-48
Diamond, R.J. 1983: Outpatient use of a double-blind medication trial: a clinical example Journal of Clinical Psychiatry 44(8): 304-305
Guernsey, B.G.; Ingrim, N.B.; Grant, J.A.; Hokanson, J.A.; Kluge, R.M.; Doutré, W.H.; Galvan, E. 1983: Use of a medication cart to integrate pharmaceutical services in an outpatient clinic American Journal of Hospital Pharmacy 40(9): 1539-1540
Sugai, D.Y.; Gustafson, C.J.; De Luca, J.F.; Davis, S.A.; Jorizzo, J.L.; O'Rourke, K.S.; Feldman, S.R. 2014: Trends in the outpatient medication management of lupus erythematosus in the United States Journal of Drugs in Dermatology: Jdd 13(5): 545-552
Christensen, P.R. 1980: Drug administration problems in home nursing: proposal for a safer system with better supervision Sygeplejersken 80(3): 16-18
2010: Drug companies monitor prescriptions and sales to fine-tune their marketing strategies Prescrire International 19(107): 140-141
Forestier, F. 1975: Biological supervision of heparin therapy Phlebologie 28(1): 19-22
Mihălţan, F.; Ulmeanu, R. 2000: Nicotine - drug or medication ? Pneumologia 49(3): 211-217
Sbarbaro, J.A. 1980: Public health aspects of tuberculosis: supervision of therapy Clinics in Chest Medicine 1(2): 253-263
Lokich, J.J. 1978: CEA: a monitor of therapy for breast and colon cancer American Family Physician 17(4): 173-176
Dimitrova, Z.D.; Petkova, V.B. 2000: Cancer, drug medication and noncompliance Bollettino Chimico Farmaceutico 139(3): 146-148
Wheeler, D.; Avis, J.M.; Miller, L.A.; Chaney, S. 1986: Rethinking family therapy education and supervision a feminist model Journal of Psychotherapy and the Family 1(4): 53-72, 1985
Swerlick, R.A.; Campbell, C.F. 2013: Medication dyes as a source of drug allergy Journal of Drugs in Dermatology: Jdd 12(1): 99-102
Jordan, M.R.; Bennett, D.E.; Bertagnolio, S.; Gilks, C.F.; Sutherland, D. 2008: World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites Antiviral Therapy 13 Suppl. 2: 15-23
Maplethorpe, F.; Dixon, J.; Rush, B. 2014: Participation in clinical supervision (PACS): an evaluation of student nurse clinical supervision facilitated by mental health service users Nurse Education in Practice 14(2): 183-187
Mannesse, C.K.; van der Cammen, T.J.M. 2003: Adverse drug reactions in three older patients, even without changes in medication Nederlands Tijdschrift Voor Geneeskunde 147(13): 585-587
Perlman, B.; Hogben, G. 1977: Effects of changes in standing medication distribution times on PRN drug use Diseases of the Nervous System 38(3): 181-185